Search Within

Neeta Pandit-Taskar

  1. "Brian Serencsits"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Molecular Imaging and Therapy Service (7)
  2. Radiology, Department of (7)
  3. Medical Physics (3)
  4. Advanced Practice Providers (2)
  5. Neuro-Oncology Service (2)
  6. Nursing (2)

More Groups

People
  1. Brian Serencsits (7)
  2. Bae Chu (2)
  3. Kavya Prasad (2)
  4. Kim Kramer (2)
  5. Lawrence Dauer (2)
  6. Maria Donzelli (2)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (1)
Publications
  1. Journal of Nuclear Medicine (3)
  2. European Journal of Nuclear Medicine and Molecular Imaging (2)
  3. EJNMMI Research (1)
  4. Journal of Nuclear Medicine Technology (1)
Publishers
  1. Society of Nuclear Medicine (3)
  2. Springer (3)
  3. Society of Nuclear Medicine and Molecular Imaging (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mathematical modeling of exposure measurements following high-dose targeted therapy using 131I-apamistamab: Analysis from the large multicenter phase III SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Chen, L. Y.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Modeling-based assessment of exposure measurements after high-dose targeted (131)I-apamistamab: Results and analyses from the phase III SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Chen, L.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Theranostic intratumoral convection-enhanced delivery of (124)I-omburtamab in patients with diffuse intrinsic pontine glioma: Pharmacokinetics and lesion dosimetry
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Grkovski, M.; Donzelli, M.; Vietri, S. M.; Horan, C.; Serencsits, B.; Prasad, K.; Lyashchenko, S.; Kramer, K.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with (131)I-omburtamab for leptomeningeal disease
    Journal Article

    Prasad, K.; Serencsits, B. E.; Chu, B. P.; Dauer, L. T.; Donzelli, M.; Basu, E.; Kramer, K.; Pandit-Taskar, N.
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Administration and radiation safety of high-dose Iomab-B (I131-apamistamab) demonstrated in multiple clinical settings: Experience from the large multicenter phase 3 SIERRA trial for targeted conditioning of patients with relapsed/refractory AML
    Meeting Abstract

    Serencsits, B.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; McNamara, K.; Desai, A.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Feasibility of high- dose targeted radiation with I131apamistamab in patients with relapsed/refractory AML: Dosimetry and radiation safety experience from the phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; Serencsits, B.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Radiation safety considerations and clinical advantages of alpha-emitting therapy radionuclides
    Journal Article

    Serencsits, B.; Chu, B. P.; Pandit-Taskar, N.; McDevitt, M. R.; Dauer, L. T.
    Journal of Nuclear Medicine Technology (2022)

    Fulltext@MSK | Save